Literature DB >> 28178697

Obesity and Kidney Disease: Hidden Consequences of the Epidemic.

Csaba P Kovesdy1, Susan L Furth, Carmine Zoccali.   

Abstract

Obesity has become a worldwide epidemic, and its prevalence has been projected to grow by 40% in the next decade. This increasing prevalence has implications for the risk of diabetes, cardiovascular disease, and also for chronic kidney disease. A high body mass index is one of the strongest risk factors for new-onset chronic kidney disease. In individuals affected by obesity, a compensatory hyperfiltration occurs to meet the heightened metabolic demands of the increased body weight. The increase in intraglomerular pressure can damage the kidneys and raise the risk of developing chronic kidney disease in the long-term. The incidence of obesity-related glomerulopathy has increased 10-fold in recent years. Obesity has also been shown to be a risk factor for nephrolithiasis, and for a number of malignancies including kidney cancer. This year, the World Kidney Day promotes education on the harmful consequences of obesity and its association with kidney disease, advocating healthy lifestyle and health policy measures that make preventive behaviors an affordable option.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2017        PMID: 28178697     DOI: 10.1159/000458467

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  10 in total

Review 1.  The Essential Element Manganese, Oxidative Stress, and Metabolic Diseases: Links and Interactions.

Authors:  Longman Li; Xiaobo Yang
Journal:  Oxid Med Cell Longev       Date:  2018-04-05       Impact factor: 6.543

2.  The Triglyceride-Glucose Index and Obesity-Related Risk of End-Stage Kidney Disease in Austrian Adults.

Authors:  Josef Fritz; Wolfgang Brozek; Hans Concin; Gabriele Nagel; Julia Kerschbaum; Karl Lhotta; Hanno Ulmer; Emanuel Zitt
Journal:  JAMA Netw Open       Date:  2021-03-01

3.  Underweight and Weight Change Increases End-Stage Renal Disease Risk in Patients with Diabetes: A Nationwide Population-Based Cohort Study.

Authors:  Eun Hui Bae; Tae Ryom Oh; Sang Heon Suh; Eun Mi Yang; Hong Sang Choi; Chang Seong Kim; Seong Kwon Ma; Bongseong Kim; Kyung-Do Han; Soo Wan Kim
Journal:  Nutrients       Date:  2021-12-29       Impact factor: 5.717

4.  Novel Role of Gestational Hydralazine in Limiting Maternal and Dietary Obesity-Related Chronic Kidney Disease.

Authors:  Benjamin P Larkin; Long T Nguyen; Miao Hou; Sarah J Glastras; Hui Chen; Rosy Wang; Carol A Pollock; Sonia Saad
Journal:  Front Cell Dev Biol       Date:  2021-08-18

5.  Causal relationship of excess body weight on cardiovascular events through risk factors.

Authors:  Thosaphol Limpijankit; Prin Vathesatogkit; Dujrudee Matchariyakul; Sirichai Wiriyatanakorn; Sukanya Siriyotha; Ammarin Thakkinstian; Piyamitr Sritara
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

6.  Low-dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity-related chronic kidney disease.

Authors:  Benjamin P Larkin; Long T Nguyen; Miao Hou; Sarah J Glastras; Hui Chen; Alen Faiz; Jason Chen; Rosy Wang; Carol A Pollock; Sonia Saad
Journal:  Diabetes Obes Metab       Date:  2022-06-29       Impact factor: 6.408

7.  Weight change and microvascular outcomes in patients with new-onset diabetes: a nationwide cohort study.

Authors:  Eun Sil Koh; Kyung Do Han; Mee Kyoung Kim; Eun Sook Kim; Min-Kyung Lee; Ga Eun Nam; Hyuk-Sang Kwon
Journal:  Korean J Intern Med       Date:  2021-05-13       Impact factor: 2.884

Review 8.  The NLPR3 inflammasome and obesity-related kidney disease.

Authors:  Ben Ke; Wen Shen; Xiangdong Fang; Qinghua Wu
Journal:  J Cell Mol Med       Date:  2017-08-31       Impact factor: 5.310

9.  Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study.

Authors:  Andrew Whittaker; Åsa M Kragh; Judith Hartleib-Geschwindner; Muna Albayaty; Anna Backlund; Peter J Greasley; Maria Heijer; Magnus Kjaer; Pablo Forte; Robert Unwin; Linda Wernevik; Hans Ericsson
Journal:  Clin Transl Sci       Date:  2019-10-30       Impact factor: 4.689

10.  The failure of glomerular filtration rate estimating equations among obese population.

Authors:  Piyawan Kittiskulnam; Krittaya Tiskajornsiri; Pisut Katavetin; Tawatchai Chaiwatanarat; Somchai Eiam-Ong; Kearkiat Praditpornsilpa
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.